Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 12, Issue 4
Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Case report
Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination
Online download statistics by month:
Online download statistics by month: April 2024 to March 2026
Abstract
Full
Pdf
Apr 2024
634
639
139
May 2024
397
400
178
Jun 2024
241
245
125
Jul 2024
155
156
160
Aug 2024
95
88
46
Sep 2024
108
113
112
Oct 2024
109
109
120
Nov 2024
103
103
30
Dec 2024
88
93
37
Jan 2025
116
116
46
Feb 2025
189
187
36
Mar 2025
103
101
30
Apr 2025
124
123
52
May 2025
105
106
47
Jun 2025
33
33
23
Jul 2025
1
1
0
Dec 2025
2
0
0
Jan 2026
2
0
0
Mar 2026
2
0
0
Total
2607
2613
1181
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF